Cargando…
Cutaneous T-cell Lymphoma Progression: A Potential Dupilumab Pitfall
Dupilumab is a monoclonal antibody inhibiting key drivers in the inflammatory signaling cascade. It has been considered a saving grace for many patients suffering from severe atopic dermatitis and has quickly become a widespread treatment option for many inflammatory pathologies. However, recent rep...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475311/ https://www.ncbi.nlm.nih.gov/pubmed/37667719 http://dx.doi.org/10.7759/cureus.42959 |